In contrast, STAT3 mutation is much less common (about 20%), but phosphorylated STAT3 (pSTAT3) is constitutively expressed in about 75% of NKTCL patients [86, 87]. This evidence concerns the gene STAT3 and extranodal nasal NK/T cell lymphoma.